LIMN
LIMN
NASDAQ · Biotechnology

Liminatus Pharma Inc-Cl A

$1.84
-0.21 (-10.24%)
As of Feb 8, 2:18 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 7.61M 6.76M 8.11M
Net Income 881.2K 841.9K 1.08M
EPS
Profit Margin 11.6% 12.5% 13.3%
Rev Growth -2.4% +10.1% +12.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.12M 4.73M 4.09M
Total Equity 22.23M 21.00M 21.13M
D/E Ratio 0.23 0.23 0.19
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.17M 1.13M 1.25M
Free Cash Flow 539.3K 438.1K 671.3K